Publications by authors named "Camillo Porta"

100Publications

Exploring the Spectrum of Kidney Ciliopathies.

Diagnostics (Basel) 2020 Dec 16;10(12). Epub 2020 Dec 16.

Chair of Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari 'A. Moro', 70121 Bari, Italy.

View Article and Find Full Text PDF
December 2020

The basics of onco-nephrology in the renal clinic.

J Nephrol 2020 Dec;33(6):1143-1149

Nephrology and Dialysis Unit, Onco-Nephrology Outpatient Clinic, ASST Fatebenefratelli-Sacco, Fatebenefratelli Hospital, Piazzale Principessa Clotilde, 320121, Milan, Italy.

View Article and Find Full Text PDF
December 2020

Application of "omics" sciences to the prediction of bone metastases from breast cancer: State of the art.

J Bone Oncol 2021 Feb 5;26:100337. Epub 2020 Nov 5.

Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Piazza Giulio Cesare 11, 70124 Bari, Italy.

View Article and Find Full Text PDF
February 2021

An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic renal-cell carcinoma patients: the 'Pamerit' study.

Jpn J Clin Oncol 2020 Nov 20. Epub 2020 Nov 20.

Department of Internal Medicine and Therapeutics, University of Pavia, and Division of Translational Oncology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy.

View Article and Find Full Text PDF
November 2020

Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions.

Oncoimmunology 2020 10 27;9(1):1832348. Epub 2020 Oct 27.

Team Pancreatic Cancer, Centre De Recherche En Cancérologie De Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique Et Technologique De Luminy, Marseille, France.

View Article and Find Full Text PDF
October 2020

The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?

Front Immunol 2020 8;11:574271. Epub 2020 Oct 8.

Clinical Pathology, Center of Molecular Medicine, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.

View Article and Find Full Text PDF
October 2020

Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal Cancer.

Front Oncol 2020 25;10:581130. Epub 2020 Sep 25.

Department of Biomedical Sciences and Clinical Oncology, University of Bari Aldo Moro, Bari, Italy.

View Article and Find Full Text PDF
September 2020

Large Extracellular Vesicles-A New Frontier of Liquid Biopsy in Oncology.

Int J Mol Sci 2020 Sep 7;21(18). Epub 2020 Sep 7.

Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro', 70121 Bari, Italy.

View Article and Find Full Text PDF
September 2020

An evaluation of UGN-101, a sustained-release hydrogel polymer-based formulation containing mitomycin-C, for the treatment of upper urothelial carcinomas.

Expert Opin Pharmacother 2020 Dec 1;21(18):2199-2204. Epub 2020 Sep 1.

Department of Emergency and Organ Transplantation, Urology, Andrology, and Kidney Transplantation Unit, University of Bari 'A. Moro' , Bari, Italy.

View Article and Find Full Text PDF
December 2020

Safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma: a systematic review and meta-analysis.

Expert Opin Drug Saf 2020 Oct 8;19(10):1329-1338. Epub 2020 Sep 8.

Chair of Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari 'A. Moro' , Bari, Italy.

View Article and Find Full Text PDF
October 2020

Non-Melanoma Skin Cancers: Biological and Clinical Features.

Int J Mol Sci 2020 Jul 29;21(15). Epub 2020 Jul 29.

Section of Medical Oncology, Department of Biomedical Sciences and Clinical Oncology (DIMO), University of Bari 'Aldo Moro', 70121 Bari, Italy.

View Article and Find Full Text PDF
July 2020

Patients with sarcomatoid renal cell carcinoma - re-defining the first-line of treatment: A meta-analysis of randomised clinical trials with immune checkpoint inhibitors.

Eur J Cancer 2020 09 23;136:195-203. Epub 2020 Jul 23.

Medical Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168 Rome, Italy.

View Article and Find Full Text PDF
September 2020

RETRACTION: The biological mechanism involved in anticancer properties of amniotic membrane.

Authors:
Camillo Porta

Oncol Rev 2020 02 27;14(1):493. Epub 2020 Apr 27.

Department of Biomedical Sciences and Human Oncology, University of Bari 'A. Moro', Bari, Italy.

View Article and Find Full Text PDF
February 2020

Editorial debate: Challenges an oncologist has to face during the SARS-CoV-2 pandemic within a universal healthcare system.

Authors:
Camillo Porta

ESMO Open 2020 05;5(3)

Dept. of Biomedical Sciences and Human Oncology, University of Bari 'A. Moro', Pavia, Italy

View Article and Find Full Text PDF
May 2020

Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers.

Crit Rev Oncol Hematol 2020 Oct 25;154:102891. Epub 2020 Apr 25.

Unit of Medical Oncology, Department of Internal Medicine, University of Wien, Austria. Electronic address:

View Article and Find Full Text PDF
October 2020

Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors.

Front Immunol 2020 20;11:490. Epub 2020 Mar 20.

Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.

View Article and Find Full Text PDF
March 2020

Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs.

Cancer Treat Rev 2020 Mar 17;84:101966. Epub 2020 Jan 17.

Clinical Division of Oncology, Department of Medicine I and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

View Article and Find Full Text PDF
March 2020

Correction to: Vitamin K effects in human health: new insights beyond bone and cardiovascular health.

J Nephrol 2020 Apr;33(2):389

Division of Nephrology, Department of Medicine, Columbia University Medical Center, 622 West 168th Street, PH2-124, New York City, NY, 10032, USA.

View Article and Find Full Text PDF
April 2020

Vitamin K effects in human health: new insights beyond bone and cardiovascular health.

J Nephrol 2020 Apr 19;33(2):239-249. Epub 2019 Dec 19.

Division of Nephrology, Department of Medicine, Columbia University Medical Center, 622 West 168th Street, PH2-124, New York City, NY, 10032, USA.

View Article and Find Full Text PDF
April 2020

Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers.

Crit Rev Oncol Hematol 2019 Dec 26;144:102812. Epub 2019 Sep 26.

Unit of Medical Oncology, Department of Internal Medicine, University of Wien, Austria. Electronic address:

View Article and Find Full Text PDF
December 2019

Drug resistance in papillary RCC: from putative mechanisms to clinical practicalities.

Nat Rev Urol 2019 11 10;16(11):655-673. Epub 2019 Oct 10.

Department of Oncology, Military Institute of Medicine, Warsaw, Poland.

View Article and Find Full Text PDF
November 2019

COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma.

Clin Genitourin Cancer 2019 12 6;17(6):425-435.e4. Epub 2019 Feb 6.

Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.

View Article and Find Full Text PDF
December 2019

Metastatic renal cell carcinoma cells growing in 3D on poly‑D‑lysine or laminin present a stem‑like phenotype and drug resistance.

Oncol Rep 2019 Nov 18;42(5):1878-1892. Epub 2019 Sep 18.

Department of Oncology with Laboratory of Molecular Oncology, Military Institute of Medicine, 04‑141 Warsaw, Poland.

View Article and Find Full Text PDF
November 2019

Renal cell carcinoma treatment after first-line combinations.

Lancet Oncol 2019 10 16;20(10):1332-1334. Epub 2019 Aug 16.

Medical University of Vienna, Vienna, Austria.

View Article and Find Full Text PDF
October 2019

Understanding the Mechanisms of Resistance in -Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy.

Int J Mol Sci 2019 Aug 14;20(16). Epub 2019 Aug 14.

Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

View Article and Find Full Text PDF
August 2019

Intracellular Chloride Ion Channel Protein-1 Expression in Clear Cell Renal Cell Carcinoma.

Cancer Genomics Proteomics 2019 Jul-Aug;16(4):299-307

Department of Microscopic Morphology/Histology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.

View Article and Find Full Text PDF
December 2019

Immune-based combination therapy for metastatic kidney cancer.

Nat Rev Nephrol 2019 06;15(6):324-325

Division of Translational Oncology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy.

View Article and Find Full Text PDF
June 2019

The adjuvant treatment of kidney cancer: a multidisciplinary outlook.

Nat Rev Nephrol 2019 07;15(7):423-433

Department of Urology, Netherlands Cancer Institute, Amsterdam, Netherlands.

View Article and Find Full Text PDF
July 2019

Medical Treatment of Advanced Hepatocellular Carcinoma Patients: The Issue Is Not the Right Drug, but the Right Patient.

Hepatology 2019 07 13;70(1):429-430. Epub 2019 Mar 13.

Division of Medical Oncology, Azienda Ospedaliero-Universitaria, Parma, Italy.

View Article and Find Full Text PDF
July 2019

Targeting angiogenesis in metastatic renal cell carcinoma.

Expert Rev Anticancer Ther 2019 03 6;19(3):245-257. Epub 2019 Feb 6.

a Division of Translational Oncology , I.R.C.C.S. Istituti Clinici Scientifici Maugeri , Pavia , Italy.

View Article and Find Full Text PDF
March 2019

The role of endothelial colony forming cells in kidney cancer's pathogenesis, and in resistance to anti-VEGFR agents and mTOR inhibitors: A speculative review.

Crit Rev Oncol Hematol 2018 Dec 18;132:89-99. Epub 2018 Sep 18.

Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S.) Policlinico San Matteo Foundation, Piazzale Golgi 19, 27100, Pavia, Italy; present address: Department of Internal Medicine, University of Pavia, and Division of Translational Oncology, IRCCS Istituti Clinici Scientifici Maugeri, via S. Maugeri 10, 27100 Pavia, Italy. Electronic address:

View Article and Find Full Text PDF
December 2018

Angiogenic and immunological pathways in metastatic renal cell carcinoma: A counteracting paradigm or two faces of the same medal? The GIANUS Review.

Crit Rev Oncol Hematol 2019 Jul 1;139:149-157. Epub 2018 Aug 1.

Unit of Immunotherapy of Human Tumors, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address:

View Article and Find Full Text PDF
July 2019

Second-line cabozantinib versus nivolumab in advanced renal cell carcinoma: Systematic review and indirect treatment comparison.

Crit Rev Oncol Hematol 2019 Jul 24;139:143-148. Epub 2018 Oct 24.

Ipsen Pharma SAS, 65 quai Georges Gorse, Boulogne-Billancourt, Ile-de-France, France. Electronic address:

View Article and Find Full Text PDF
July 2019

Kidney transplantation in patients with previous renal cancer: a critical appraisal of current evidence and guidelines.

J Nephrol 2019 Feb 16;32(1):57-64. Epub 2018 Oct 16.

Medical Oncology, I.R.C.C.S. San Matteo University Hospital Foundation, Pavia, Italy.

View Article and Find Full Text PDF
February 2019

The role of tivozanib in advanced renal cell carcinoma therapy.

Expert Rev Anticancer Ther 2018 11 21;18(11):1113-1124. Epub 2018 Aug 21.

f Genitourinary Oncology Service, Department of Medicine , Memorial Sloan Kettering Cancer Center , New York , NY , USA.

View Article and Find Full Text PDF
November 2018

Opening an onconephrology clinic: recommendations and basic requirements.

Nephrol Dial Transplant 2018 09;33(9):1503-1510

Onco-Nephrology Clinic, Nephrology and Dialysis Unit, San Carlo Borromeo Hospital, ASST Santi Carlo e Paolo, Milan, Italy.

View Article and Find Full Text PDF
September 2018

Sunitinib in the treatment of renal cell carcinoma: an update on recent evidence.

Ther Adv Urol 2017 Aug 29;9(8):195-207. Epub 2017 Jun 29.

Medical Oncology, I.R.C.C.S. San Matteo University Hospital Foundation, Piazzale C. Golgi 19, 27100 Pavia, Italy.

View Article and Find Full Text PDF
August 2017

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.

N Engl J Med 2018 Apr 21;378(14):1277-1290. Epub 2018 Mar 21.

From Memorial Sloan Kettering Cancer Center, New York (R.J.M.), and Roswell Park Cancer Institute, Buffalo (S.G.) - both in New York; University of Texas M.D. Anderson Cancer Center, Houston (N.M.T., P. Sharma); Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center (D.F.M.), and Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School (T.K.C.), Boston; Centro Internacional de Estudios Clínicos (O.A.F.) and Fundación Arturo López Pérez (P. Salman), Santiago, Chile; Palacký University and University Hospital Olomouc, Olomouc, Czech Republic (B.M.); Fox Chase Cancer Center, Philadelphia (E.R.P.); Hôpitaux Universitaires de Strasbourg, Strasbourg (P.B.), Bordeaux University Hospital, Hôpital Saint-André, Bordeaux (A.R.), and Institut Gustave Roussy, Villejuif (B.E.) - all in France; Istituto di Ricovero e Cura a Carattere Scientifico San Matteo University Hospital Foundation, Pavia (C.P.), and Ospedale San Donato, Azienda Unità Sanitaria Locale Toscana Sud-Est, Istituto Toscano Tumori, Arezzo (S.B.) - both in Italy; Barts Cancer Institute, Cancer Research UK Experimental Cancer Medicine Centre, Queen Mary University of London, Royal Free NHS Trust (T.P.), and Cancer Research UK (R.H.), London; Aarhus University Hospital, Aarhus, Denmark (F.D.); Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv - both in Israel (V.N.); British Columbia Cancer Agency, Vancouver, Canada (C.K.K.); Westmead Hospital and Macquarie University, Sydney (H.G.); Jena University Hospital, Jena, Germany (M.-O.G.); Centro de Pesquisa em Oncologia, Hospital São Lucas, Porto Alegre, Brazil (C.H.B.); Niigata University, Niigata, Japan (Y.T.); Hospital Universitario 12 de Octubre, Madrid (D.C.); Cleveland Clinic Taussig Cancer Institute, Cleveland (B.I.R.); Bristol-Myers Squibb, Princeton, NJ (A.C.C., S.M., M.B.M., M.W.-R., J.D.); and Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore (H.J.H.).

View Article and Find Full Text PDF
April 2018

Culture in embryonic kidney serum and xeno-free media as renal cell carcinoma and renal cell carcinoma cancer stem cells research model.

Cytotechnology 2018 Apr 17;70(2):761-782. Epub 2018 Feb 17.

Department of Oncology, Military Institute of Medicine, Szaserów 128, 04-141, Warsaw, Poland.

View Article and Find Full Text PDF
April 2018

Acute Kidney Injury in Cancer Patients.

Contrib Nephrol 2018 23;193:137-148. Epub 2018 Jan 23.

View Article and Find Full Text PDF
April 2019

Renin angiotensin system deregulation as renal cancer risk factor.

Oncol Lett 2017 Nov 25;14(5):5059-5068. Epub 2017 Aug 25.

Department of Oncology, Military Institute of Medicine, 04-141 Warsaw, Poland.

View Article and Find Full Text PDF
November 2017

Adjuvant therapy in renal cell carcinoma.

Cancer Treat Rev 2017 Nov 23;60:152-157. Epub 2017 Sep 23.

Department of Medical Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada.

View Article and Find Full Text PDF
November 2017

Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient.

Front Pharmacol 2017 21;8:329. Epub 2017 Jun 21.

Department of Oncology with Laboratory of Molecular Oncology, Military Institute of MedicineWarsaw, Poland.

View Article and Find Full Text PDF
June 2017